Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fenfluramine analog
- Development stage
- Preclinical
- Lead developer
- UCB
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fenfluramine analog is a small molecule serotonin (5-HT) releaser being developed by EQUULUS Therapeutics for the treatment of obesity and seizure disorders. Currently in the discovery phase, the drug is designed as an analog of fenfluramine, a known serotonergic agent. By acting as a serotonin releaser, the compound aims to modulate central nervous system pathways involved in appetite regulation and neuronal excitability, potentially offering a therapeutic option for metabolic and neurological conditions while aiming for an optimized safety profile compared to legacy compounds.
- Other names
- Fenfluramine Analog
02
Targets
SERT (Sodium-dependent serotonin transporter)HTR4 (5-Hydroxytryptamine receptor 4)HTR2A (Serotonin receptor 5-HT2A)HTR1D (5-hydroxytryptamine receptor 1D)SIGMAR1 (Sigma non-opioid intracellular receptor 1)HTR2C (5-hydroxytryptamine 2C receptor)
Beyond the preview
Go deeper on fenfluramine analog.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fenfluramine analog.